Showing results (61-70 of 742) with videos related to
Sort By:
Pageof 75
Pharmacopsychiatry|July 7, 2011
Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidolN R B Raposo, A S Ferreira, W F GattazNeuroscience Research|February 1, 1986
Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain diseaseK Rissler, H Cramer, D Schaudt, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|September 9, 2008
Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trialA Diehl, I Reinhard, A Schmitt, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parametersW F Gattaz, S Mayer, P Ziegler, et al.Biological Psychiatry|October 1, 1993
REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depressionM Bahro, D Riemann, G Stadtmüller, et al.Psychopharmacology|January 1, 1995
Oral tardive dyskinesia: validation of a measuring device using digital image processingC Büchel, J de Leon, G M Simpson, et al.Biological Psychiatry|January 1, 1995
Decreased phospholipase A2 activity in Alzheimer brainsW F Gattaz, A Maras, N J Cairns, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|February 1, 2005
Modulation of phospholipase A2 activity in primary cultures of rat cortical neuronsC T Mendes, W F Gattaz, E L Schaeffer, et al.Fortschritte Der Neurologie, Psychiatrie, Und Ihrer Grenzgebiete|October 1, 1978
[Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)]H BeckmannPageof 75